10954
Triggering of HLA class II antigens by the anti-HLA-DR monoclonal antibody ( mAb ) L243 significantly (P < 0.05) and differentially enhanced the release of tumor necrosis factor alpha ( TNF-alpha ) by the non-Hodgkin's lymphoma cells Ri-I , Ci-I , and Sc-I , which are at a distinct stage of B-cell differentiation , and by the more mature Burkitt lymphoma cell Raji ; in contrast, it did not induce TNF-alpha release by the pre-B leukemia cells Nalm-6 and BV173 .
 cell line: Burkitt lymphoma cell Raji; cell line: Nalm-6; cell line: Ci-I; protein: anti-HLA-DR monoclonal antibody; protein: anti-HLA-DR monoclonal antibody ( mAb ) L243; cell line: Sc-I; cell type: pre-B leukemia cells; protein: TNF-alpha; cell type: non-Hodgkin's lymphoma cells; protein: TNF-alpha; protein: tumor necrosis factor alpha; cell line: Ri-I; cell line: BV173; protein: mAb; protein: HLA class II antigens
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: cell line, protein, RNA, DNA, cell type 
Text: {0} 
 Entities: Burkitt lymphoma cell Raji, Nalm-6, Ci-I, anti-HLA-DR monoclonal antibody, anti-HLA-DR monoclonal antibody ( mAb ) L243, Sc-I, pre-B leukemia cells, TNF-alpha, non-Hodgkin's lymphoma cells, TNF-alpha, tumor necrosis factor alpha, Ri-I, BV173, mAb, HLA class II antigens 
Answer:
 cell line: Burkitt lymphoma cell Raji; cell line: Nalm-6; cell line: Ci-I; protein: anti-HLA-DR monoclonal antibody; protein: anti-HLA-DR monoclonal antibody ( mAb ) L243; cell line: Sc-I; cell type: pre-B leukemia cells; protein: TNF-alpha; cell type: non-Hodgkin's lymphoma cells; protein: TNF-alpha; protein: tumor necrosis factor alpha; cell line: Ri-I; cell line: BV173; protein: mAb; protein: HLA class II antigens